ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Sclerosis (MS) in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Sclerosis
Multiple Sclerosis
Relapsing-Remitting Multiple Sclerosis
Chronic Progressive Multiple Sclerosis
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Muscle Spasticity

Multiple Sclerosis (MS) trials near San Diego, CA, USA:

Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis (NEOS)

Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...

Enrolling
Multiple Sclerosis (MS)
Other: Ofatumumab placebo
Drug: Siponimod

Phase 3

Novartis
Novartis

San Diego, California, United States and 73 other locations

This study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple...

Enrolling
Multiple Sclerosis, Relapsing-Remitting
Drug: Interferon beta type 1a
Drug: BIIB017 (peginterferon beta-1a)

Phase 3

Biogen
Biogen

La Jolla, California, United States and 65 other locations

with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and \< 18 years over a dura...

Enrolling
Relapsing-Remitting Multiple Sclerosis
Other: Ocrelizumab Placebo
Drug: Ocrelizumab

Phase 3

Roche
Roche

La Jolla, California, United States and 120 other locations

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Remibrutinib

Phase 3

Novartis
Novartis

Chula Vista, California, United States and 211 other locations

in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...

Enrolling
Multiple Sclerosis
Drug: Activated charcoal
Drug: Cholestyramine

Phase 3

Sanofi
Sanofi

Carlsbad, California, United States and 82 other locations

It is an open label study to evaluate safety, tolerability and brain microglia response in participants with ALS following multiple doses of...

Enrolling
Amyotrophic Lateral Sclerosis
Drug: BLZ945

Phase 2

Novartis
Novartis

La Jolla, California, United States and 9 other locations

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...

Enrolling
Multiple Sclerosis
Drug: Frexalimab
Drug: Placebo

Phase 3

Sanofi
Sanofi

Carlsbad, California, United States and 89 other locations

This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics of a higher dose...

Active, not recruiting
Multiple Sclerosis
Drug: Antihistamine
Drug: Ocrelizumab

Phase 3

Roche
Roche

Carlsbad, California, United States and 125 other locations

The ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS)....

Active, not recruiting
Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: BIIB105

Phase 1, Phase 2

Biogen
Biogen

La Jolla, California, United States and 16 other locations

A Phase I Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis to demonstrate safety \& eff...

Not yet enrolling
Multiple Sclerosis
Biological: NeuroVax
Biological: IFA Incomplete Freund's Adjuvant

Phase 1

Immune Response BioPharma

San Diego, California, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems